Discover Great Companies Discover Great Clients
Popularity  5.4万   |   Followers  42   |   Likes  35   |   Feedback  26 Claim this company
No.613 Suzhou City Popularity Ranking No.176 Industrial Park Jiangsu Pr No.4 Biopharmaceuticals Technology No.5 Kang Zhong Liu Yao No.7 Innovative Drugs Products No.9 Yuan Yan Yao No.10 Pharmaceutical R&D No.12 Innovative Drugs No.22 Biopharmaceuticals No.27 Pharmaceutical Technology No.27 Lin Chuang Yi Xue No.27 Zhi Yao / Yao Industries No.28 Yao Products R&D No.31 Pharmaceutical 高新技术企业 省级专精特新中小企业 省级高新技术企业 瞪羚企业 专精特新小巨人企业 市级创新型中小企业
More

Company Overview

  • Nature: Listed Company Size: More than 10,000 emp Founded: 11年
  • Industry: Pharmaceutical/Biotechnology
  • Full name: Suzhou Shengdiya Biomedical Co., Ltd.。

Development Stage

  • Ranking: Ranked #613 in Suzhou City by popularity Ranked #4 in Suzhou Biopharmaceuticals Technology Company by popularity Ranked #5 in Suzhou Kang Zhong Liu Yao Company by popularity Ranked #7 in Suzhou Innovative Drugs Products Company by popularity Ranked #9 in Suzhou Yuan Yan Yao Company by popularity
  • Honors: 高新技术企业 省级专精特新中小企业 According to algorithm
  • Salary: 76% of positions earn 8-20K, In 2026 vs last yeargrew by 5%.。Master's salary: ¥16.3K, Doctorate salary: ¥36.3K.
  • R&D: "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 48.9%, "Other (R&D and Technical)": 34%, "Scientific Research": 29.8%。
  • Recruiting: In 2026 vs 2025decreased by 56%.
  • Requirement: Education: 本科 leads with 44%. Experience: 不限 leads with 70%.
  • Region: Distributed across 2 regions, 苏州: 70%, 连云港: 26%, 上海: 4%.

About the Company

Suzhou Shengdiya Biomedical Co., Ltd. is a wholly-owned subsidiary of Jiangsu Hengrui Pharmaceutical Co., Ltd. Located beside the scenic East Sand Lake in Suzhou, Jiangsu Province, the company covers an area of 165 mu and is primarily engaged in the R&D, pilot-scale amplification, and commercial production of independently innovative biopharmaceuticals as well as biosimilars. The company plans a total investment of 1.5 billion RMB to establish an internationally competitive biopharmaceutical R&D and production base, importing world-class purification, ultrafiltration, analytical equipment, and automated formulation production lines, and building a production system that meets the quality certifications of the US FDA and the EU EMA. Currently, it has completed two 2000L-scale commercial production workshops for monoclonal antibodies and one oncolytic virus pilot workshop, equipped with an imported integrated washing, sterilizing, filling, and capping line with a production capacity of approximately 1.5 million bottles. In 2019, six additional 2000L single-use system production lines were added, bringing the total reaction volume to 24,000L. Suzhou Shengdiya Biomedical Co., Ltd. keeps pace with the group's strategy, actively promoting technological innovation and internationalization. In September 2015, the company licensed the overseas rights of its proprietary PD-1 biological innovative drug for tumor immunotherapy to the US company Incyte Pharmaceuticals, with an upfront payment of $25 million and milestone payments totaling $770 million, marking the first time a Chinese enterprise transitioned from importing US biomedical technology to exporting innovative technology. In 2016, the company successfully introduced an oncolytic adenovirus product from Japan's Oncolys BioPharma, supplementing its tumor immunotherapy pipeline and enhancing its competitiveness in the anti-tumor field. At the same time, the company is accelerating the overseas clinical progress of its innovative drugs. Currently, PD-L1 innovative drugs are undergoing clinical studies in the United States and Australia, aiming to ultimately achieve overseas sales of innovative drugs. Leveraging Hengrui Pharmaceutical's financial, technical, and talent support, the company will build and improve its commercial production and process development teams, hiring professional technical talents at all levels, with doctoral, master's, and returnee high-tech talents accounting for over 80% of the workforce. Additionally, in collaboration with Shanghai Hengrui, the company is increasing R&D investment, accelerating the pace of innovative R&D and industrialization, with some project achievements to be submitted for national programs such as the "Major New Drug Creation" special project and the National Spark Plan.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Shengdiya Pharmaceutical How Fast Is Hiring Growing? (2 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 44%
  • 2024: Up 22%
  • 2023: Up 181%
  • 2022: Down 65%
Shengdiya Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at Suzhou Shengdiya Biomedical Co., Ltd. growing? Shengdiya Pharmaceutical2026: 23 openings (down 56%), 2025: 52 openings (down 44%), 2024: 93 openings (up 22%), 2023: 76 openings (up 181%), 2022: 27 openings (down 65%), 2021: 77 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Shengdiya Pharmaceutical Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 73%
  • 2024: Down 25%
  • 2023: Up 122%
  • 2022: Down 40%
Shengdiya Pharmaceutical Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Suzhou Shengdiya Biomedical Co., Ltd. growing? Shengdiya PharmaceuticalMaster's recruitment over the years: 2025: 4 openings (down 73%), 2024: 15 openings (down 25%), 2023: 20 openings (up 122%), 2022: 9 openings (down 40%), 2021: 15 openings.

Shengdiya Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
Flat
Growth Rate
2026 vs 2025
  • 2025: Down 25%
  • 2024: Down 64%
  • 2023: Up 267%
  • 2022: Down 67%
Shengdiya Pharmaceutical Doctoral Hiring by Year: 2026 — same as 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Suzhou Shengdiya Biomedical Co., Ltd. growing? Shengdiya PharmaceuticalDoctorate recruitment over the years: 2026: 3 openings (flat), 2025: 3 openings (down 25%), 2024: 4 openings (down 64%), 2023: 11 openings (up 267%), 2022: 3 openings (down 67%), 2021: 9 openings.

Shengdiya Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Suzhou Shengdiya Biomedical Co., Ltd.? Based on an analysis of Shengdiya Pharmaceutical's job postings over the past year, "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 48.9%, "Other (R&D and Technical)": 34%, "Scientific Research": 29.8%, "Mechanical/Instrumentation": 6.4%, "Medical & Health/Beauty & Healthcare": 4.3%. For reference only.

Shengdiya Pharmaceutical — What Are the Salaries Like? (50 records)

Manage
Shengdiya Pharmaceutical Salary Overview
salary range: 3K - 50K, 76% of roles pay ¥8-20K
Note: salary statistics are based on 50 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Suzhou Shengdiya Biomedical Co., Ltd.?Shengdiya Pharmaceutical76% of positions earn 8-20K, Undergraduate salary: ¥。Suzhou salary ranking top 30,生物/制药/化工/环保类 average salary ¥19.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Shengdiya Pharmaceutical

(More)
Are salaries high at Suzhou Shengdiya Biomedical Co., Ltd.? We provide: Researcher, Analyst, Management Trainee, Quality, Workshop, QA, QC, Warehouse Staff, Filling Operator, Formulation Manager, Process Engineer, Purification Engineer, Cell Culture Specialist, ehs, Engineer, 体系专员, 冻干工程师, 制剂研究, 化工研发, Intern. Click to view detailed salary analysis by job.

Shengdiya Pharmaceutical honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • 生物/制药/化工/环保类
    52% of total 52%
  • 工厂生产类
    34% of total 34%
  • 其他(研发和技术类)
    32% of total 32%
  • 科研类
    28% of total 28%

Education

  • 本科
    44% of total 44%
  • 硕士
    26% of total 26%
  • 大专
    22% of total 22%
  • 博士
    8% of total 8%

Experience

  • 不限
    70% of total 70%
  • 3-5年
    18% of total 18%
  • 1-3年
    6% of total 6%
  • 5-10年
    6% of total 6%
View Detailed Analysis

What does Suzhou Shengdiya Biomedical Co., Ltd. require? Who is Shengdiya Pharmaceutical hiring? Shengdiya Pharmaceutical recruitment: 生物/制药/化工/环保类占比最多占52%,其次是工厂生产类占34%. What education can get in at Shengdiya Pharmaceutical? 本科占比最多占44%,其次是硕士占26%. High education required at Shengdiya Pharmaceutical? 硕士占26%,博士占8%. Work experience required at Shengdiya Pharmaceutical? 不限占比最多占70%,其次是3-5年占18%. Where are the job locations at Shengdiya Pharmaceutical? 苏州占比最多占70%,其次是连云港占26%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 10,000万(元)
Legal Representative: 顾熠峰
Date Established:
Credit Code: 91320594355003673J
Registered Address: 中国(江苏)自由贸易试验区苏州片区苏州工业园区凤里街350号

Partners & Suppliers

公司为其抗体药物提供CDMO服务 Source
供应商 重组蛋白与抗体药物
作为恒瑞医药子公司,采购纳微科技的色谱填料用于研发与生产 Source
供应商 生物医药色谱填料
苏州盛迪亚与博威生物签署战略合作协议,共同开发生物类似药 Source
供应商 生物药研发服务

People who follow Shengdiya Pharmaceutical also follow

Shengdiya Pharmaceutical Competitors (Similar Companies)

“Research, development, and production of anti-tumor and surgical medic”
“To develop high-quality biologics that are accessible and affordable f”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“Let the light of life science shine into every corner of the earth”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Committed to developing innovative drugs in therapeutic areas such as ”
“Improving people's quality of life”
“Bringing better treatment options to cancer patients worldwide”
“Making drugs and cures accessible to all”
“Seek and strive, protect and heal all beings”
试剂 化学制药 医药原料 生物医药
“Developing and producing high-grade, high-tech photosensitive new mate”
“A high-tech enterprise specializing in outsourced biomedical R&D servi”
动物营养 化妆品 精细化工 维生素
“中国胶粘剂工业协会副会长”

Discover Great Companies, Discover Great Clients

苏州公司名录 苏州“Industrial Park”公司名录 苏州“医药”公司名录 苏州“生物医药”公司名录 苏州“创新药”公司名录 苏州“制药/药业”公司名录 苏州“抗肿瘤药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates